RxPreferred flips the script on rising healthcare costs with Mark Cuban Cost Plus Drug Company, offering Humira® Biosimilar, YUSIMRY™, to plans and members.

RxPreferred’s inclusion of YUSIMRY™ will have a significant impact on employer-sponsored health plans and their members with the biosimilar representing a 92% discount from the list price for Humira®. The blockbuster move will improve access to medication for patients that previously…